Sofia, Bulgaria, August 5, 2019 - Sopharma AD notifies that for July 2019 the Company recorded a decrease in sales of 11% compared to the same month of 2018, incl. 3% decrease in sales for the domestic market and 16% decrease in export sales.

In the first seven months of 2019 the revenues from sales of production decreased by 1% compared to the same period of 2018, incl. 10% decrease in domestic sales and 5% increase of export sales.

Sofia, Bulgaria, July 30, 2019 - Sopharma AD notifies that the Company completes H1 2019 with 10% increase of sales revenues from export markets and the main markets continue the tendency for stable growth and good performance of priority products.

Following its strategy for market diversification the company realized sales in Sweden for the first time.